Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...

For some folks, the fall to-do list should now include an important third jab—a respiratory syncytial virus (RSV) vaccine. (The FDA approved the first one in 2023.) While flu and COVID cases ...

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren't as worried about it anymore. RSV is common but can be dangerous ...

A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% protection against severe illness and/or hospitalization. With U.S ...

Timely diagnosis of RSV is imperative for optimal patient management; by rapidly identifying RSV infection, health professionals can implement appropriate infection control measures while limiting ...

BUT HOW DO YOU KNOW IF IT’S THE FLU, RSV OR COVID? TO HELP YOU UNDERSTAND THE DIFFERENCE, THIS MORNING WE WELCOME DOCTOR VANESSA WALKER WITH SUTTER HEALTH. THANK YOU SO MUCH FOR BEING HERE.

So she was delighted when, last year, health authorities in the US and Europe approved the first vaccines for respiratory syncytial virus. RSV vaccines hold the potential to reduce the thousands ...

Rates of SUID per 100,000 live births rose by 10% from 2019 to 2021. A rise in rates of sudden unexpected infant deaths may have been linked to an off-season surge of respiratory syncytial virus ...

Today, we talk about some RSV competition that’s brewing, how Alnylam’s CEO spoke about its plans with ATTR-CM, and more. Alnylam Pharmaceuticals is expanding the footprint of its RNA-based ...

The time for the cold-weather spread of COVID-19, influenza and respiratory syncytial virus (RSV) is quickly approaching. With it comes a new wave of illnesses that can result in school absences ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...